• Shire sells mRNA therapy platform to RaNA Therapeutics firstwordpharma
    January 05, 2017
    Shire sold its mRNA therapy platform to RaNA Therapeutics in return for an undisclosed equity stake, as well as future milestones and royalties on products developed with the technology, RaNA announced Wednesday.
PharmaSources Customer Service